Fellowship · Fort Sam Houston, TX
Sponsored by San Antonio Uniformed Services Health Education Consortium
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma.
Nature · 2025 · 164 citations · Bradley McGregor
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
The New England journal of medicine · 2025 · 134 citations · Bradley McGregor
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.
Cancer cell · 2021 · 507 citations · Bradley McGregor
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
Cancer cell · 2021 · 409 citations · Bradley McGregor
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial.
The Lancet. Oncology · 2021 · 248 citations · Bradley McGregor
Developing national cancer survivorship standards to inform quality of care in the United States using a consensus approach.
Journal of cancer survivorship : research and practice · 2024 · 79 citations · Joshua Fenderson
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
The Lancet. Oncology · 2023 · 140 citations · Bradley McGregor
Whole blood at the tip of the spear: A retrospective cohort analysis of warm fresh whole blood resuscitation versus component therapy in severely injured combat casualties.
Surgery · 2022 · 75 citations · Andrew Cap